BRCA (2) ▲ Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)

Last Posted: Jan-18-2017 6AM

 BRCA expanded expanded

Genomics and the 'Angelina Jolie effect' 
Genomics Education UK, January 16, 2017

How do BRCA1 and BRCA2 mutations cause cancer?
Mainstreaming Cancer Genetics, January 12, 2017

Population screening for BRCA1/BRCA2 mutations: lessons from qualitative analysis of the screening experience.
Lieberman Sari et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Dec

More information on this topic

Last Posted: Jan 16, 2017

---

• Genomics and the 'Angelina Jolie effect' 
  Genomics Education UK, January 16, 2017
• How do BRCA1 and BRCA2 mutations cause cancer?
  Mainstreaming Cancer Genetics, January 12, 2017
• Understanding Genetic Breast Cancer Risk: Processing Loci of the BRCA Gist Intelligent Tutoring System.
  Wolfe Christopher R et al. Learning and individual differences 2016 Jul 49178-189
• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232

more

---

Most Recent Scientific Publications from Weekly Horizon Scans

From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

• Understanding Genetic Breast Cancer Risk: Processing Loci of the BRCA Gist Intelligent Tutoring System.
  Wolfe Christopher R et al. Learning and individual differences 2016 Jul 49178-189
• Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer.
  Dean Marleah et al. Health communication 2016 Dec 1-9
• Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.
  Antonucci Ivana et al. Journal of human genetics 2016 Dec
• Delivering widespread BRCA testing and PARP inhibition to patients with ovarian cancer.
  George Angela et al. Nature reviews. Clinical oncology 2016 Dec
• BRCA mutation genetic testing implications in the United States.
  Bayraktar Soley et al. Breast (Edinburgh, Scotland) 2016 Dec 31224-232

more